Consultant

Jonathan Meyer

MD
Voluntary Clinical Professor of Psychiatry
University of California, San Diego School of Medicine, La Jolla, CA

Dr. Jonathan Meyer is a Voluntary Clinical Professor of Psychiatry at University of California, San Diego, and a Distinguished Life Fellow of the American Psychiatric Association. Dr. Meyer is a graduate of Stanford University and Harvard Medical School, and finished psychiatry residency and fellowships at LA General Medical Center. Dr. Meyer has teaching duties at UC San Diego, is a Senior Academic Advisor to the California Department of State Hospitals, and is a psychopharmacology consultant to the first episode psychosis program at the Balboa Naval Medical Center.

Dr. Meyer has lectured and published extensively on psychopharmacology. Along with Dr. Stephen Stahl he is co-author of the Clozapine Handbook published in 2019, The Clinical Use of Antipsychotic Plasma Levels released in 2021, and The Lithium Handbook published in 2023, all three by Cambridge University Press.

2026 Sessions

Difficult Medicines: The Art and Science of Lithium Therapy

Lithium remains a cornerstone in mood disorder treatment, offering unparalleled efficacy for bipolar disorder and suicidality. Yet, its use requires precision in dosing, monitoring, and side effect management. This session will explore the latest insights into lithium’s mechanisms, therapeutic benefits, and best practices for clinical use. Faculty will also discuss strategies for maintaining adherence, mitigating toxicity risks, and navigating lithium use in special populations.

Speaker

Tuesday, September 15 3:30–4:30 PM
Room Great Hall A
Difficult Medicines
Consultant

Jonathan Meyer

MD
Voluntary Clinical Professor of Psychiatry
University of California, San Diego School of Medicine, La Jolla, CA

Dr. Jonathan Meyer is a Voluntary Clinical Professor of Psychiatry at University of California, San Diego, and a Distinguished Life Fellow of the American Psychiatric Association. Dr. Meyer is a graduate of Stanford University and Harvard Medical School, and finished psychiatry residency and fellowships at LA General Medical Center. Dr. Meyer has teaching duties at UC San Diego, is a Senior Academic Advisor to the California Department of State Hospitals, and is a psychopharmacology consultant to the first episode psychosis program at the Balboa Naval Medical Center.

Dr. Meyer has lectured and published extensively on psychopharmacology. Along with Dr. Stephen Stahl he is co-author of the Clozapine Handbook published in 2019, The Clinical Use of Antipsychotic Plasma Levels released in 2021, and The Lithium Handbook published in 2023, all three by Cambridge University Press.

Difficult Medicines: Navigating the Complexities of Clozapine

Clozapine remains the gold standard for treatment-resistant schizophrenia, yet its use is often limited by strict monitoring requirements, side effect concerns, and prescribing complexities. This session will provide a deep dive into the benefits, risks, and practical challenges of clozapine therapy, exploring strategies for initiating treatment, managing side effects, and ensuring adherence. Faculty will discuss real-world cases and expert recommendations to help clinicians navigate this essential but demanding medication.

Speaker

Thursday, September 17 5:00–6:00 PM
Room Great Hall A
Difficult Medicines
Consultant

Jonathan Meyer

MD
Voluntary Clinical Professor of Psychiatry
University of California, San Diego School of Medicine, La Jolla, CA

Dr. Jonathan Meyer is a Voluntary Clinical Professor of Psychiatry at University of California, San Diego, and a Distinguished Life Fellow of the American Psychiatric Association. Dr. Meyer is a graduate of Stanford University and Harvard Medical School, and finished psychiatry residency and fellowships at LA General Medical Center. Dr. Meyer has teaching duties at UC San Diego, is a Senior Academic Advisor to the California Department of State Hospitals, and is a psychopharmacology consultant to the first episode psychosis program at the Balboa Naval Medical Center.

Dr. Meyer has lectured and published extensively on psychopharmacology. Along with Dr. Stephen Stahl he is co-author of the Clozapine Handbook published in 2019, The Clinical Use of Antipsychotic Plasma Levels released in 2021, and The Lithium Handbook published in 2023, all three by Cambridge University Press.

Mind & Metabolic Matters: Practical Guidance on Prescribing GLP-1s in Psychiatry

As GLP-1 receptor agonists and dual incretin therapies become mainstream, psychiatrists increasingly encounter patients taking or requesting these medications alongside psychotropics that affect weight and metabolic risk. This high-yield session provides a practical, clinic-ready framework for patient selection and counseling, key evidence and indications, contraindication/precaution screening, safe titration, and common adverse effect prevention and management. Faculty will address psychiatric considerations including eating disorder risk, body image and weight-stigma harms, mood monitoring, addiction/craving implications, and access/adherence challenges. Participants will leave with strategies for care coordination and long-term follow-up, plus lifestyle essentials- nutrition guidance, strength-preserving activity targets, and apps/digital tools- to help patients succeed. The session closes with a brief look at emerging data and potential future psychiatric indications under study.

Speaker

Saturday, September 19 9:00–10:00 AM
Room Great Hall D
Integrative Psychiatry
Steering Committee

Brittany Albright

MD, MPH
Founder and Medical Director of Multidisciplinary and Interventional Psychiatry Practice
Sweetgrass Psychiatry; Medical University of South Carolina

Brittany Albright MD, MPH is a Harvard-trained, triple board-certified psychiatrist with clinical expertise in interventional psychiatry, addiction psychiatry, and obesity medicine. She completed her adult psychiatry residency at the nation’s top ranked program, Massachusetts General Hospital and McLean Hospital and a fellowship in addiction psychiatry at the Medical University of South Carolina, where she serves as an Affiliate Assistant Professor in the Department of Psychiatry & Behavioral Sciences. Dr. Albright is the Founder and CEO of Sweetgrass Psychiatry, South Carolina’s largest physician-owned psychiatry practice with three locations.

Her research and academic work include numerous abstracts presented at national meetings and peer-reviewed manuscripts focused on innovative treatments and psychiatric education. A national speaker and consultant, she serves as President Elect of the South Carolina Psychiatric Association and holds multiple leadership roles with Psych Congress, including co-chair of Psych Congress Elevate and originator of the Private Practice Summit.

She firmly believes in collaborative, comprehensive treatment and the restoration of wellness in her patients and practices psychotherapy with expertise in mentalization based therapy and psychodynamic therapy. She also holds certifications in psychedelic assisted psychotherapy and transcranial magnetic stimulation.

Consultant

Jonathan Meyer

MD
Voluntary Clinical Professor of Psychiatry
University of California, San Diego School of Medicine, La Jolla, CA

Dr. Jonathan Meyer is a Voluntary Clinical Professor of Psychiatry at University of California, San Diego, and a Distinguished Life Fellow of the American Psychiatric Association. Dr. Meyer is a graduate of Stanford University and Harvard Medical School, and finished psychiatry residency and fellowships at LA General Medical Center. Dr. Meyer has teaching duties at UC San Diego, is a Senior Academic Advisor to the California Department of State Hospitals, and is a psychopharmacology consultant to the first episode psychosis program at the Balboa Naval Medical Center.

Dr. Meyer has lectured and published extensively on psychopharmacology. Along with Dr. Stephen Stahl he is co-author of the Clozapine Handbook published in 2019, The Clinical Use of Antipsychotic Plasma Levels released in 2021, and The Lithium Handbook published in 2023, all three by Cambridge University Press.

Back to top